S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Dr. Reju-All Brings K-Pharmacy Skincare to Ulta Beauty Nationwide

Korean skincare brand Dr. Reju-All is making its U.S. retail debut, landing in select Ulta Beauty stores and online starting August 9, 2026. The partnership marks a significant push to bring pharmacy-grade, science-led dermatological products to American consumers seeking clinical-strength results.

Dr. Reju-All Brings K-Pharmacy Skincare to Ulta Beauty Nationwide
Photo: Bio & News

The launch collection features five signature products, including the Advanced PDRN Rejuvenating Cream and the Advanced Retino-Mela Serum. Each formulation emphasizes ingredient efficacy, reflecting a philosophy Junho Jung, founder and CEO, describes as a blend of rigorous pharmacy standards and Korean dermatological innovation. By entering the U.S. market through Ulta, the brand aims to bridge the gap between clinical credibility and accessible, high-performance skincare.

To mark the expansion, the brand will host a two-day immersive pop-up experience at The Grove in Los Angeles on August 8 and 9. The event is designed to introduce shoppers to the brand’s clinical approach through product education and interactive demonstrations. Penny Coy, Senior Vice President of Merchandising at Ulta Beauty, noted that the addition reflects a broader consumer demand for brands that prioritize science-led formulations over fleeting aesthetic trends. With a history of success across 5,000 locations in Korea, Dr. Reju-All looks to establish a permanent footprint in the U.S. beauty landscape.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!